Skip to Main Content

Author Details

Jonathan Kay
University College London
2013
15
11
PMIDPaper TitleJournal TitlePublished Year
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
30073682Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates.Prostate2018
28945760Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PLoS Genet2017
28292578Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144].EBioMedicine2017
27578825Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel.Endocr Relat Cancer2016
26572708The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.Eur Urol2016
27732966HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.Oncotarget2016
25560400HES5 silencing is an early and recurrent change in prostate tumourigenesis.Endocr Relat Cancer2015
26501111Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.EBioMedicine2015
26035357Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer.Oncotarget2015
26018901Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
25730763Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
24240687N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.Oncogene2014
22806573Method for sampling tissue for research which preserves pathological data in radical prostatectomy.Prostate2013
23880827Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress.Br J Cancer2013
  • 1 - 15 of 15

Recommended Authors

Vincent Huang
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 3
Nicholas Erho
GenomeDx Biosciences Inc.
Career Start Year 2012
Number of shared co-authors 15
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 25
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 8
Mandeep Takhar
GenomeDx Biosciences Inc.
Career Start Year 2010
Number of shared co-authors 6
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 2
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 7
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 2
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 3
Mark M Pomerantz
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 17
Alexander W Wyatt
University of British Columbia
Career Start Year 2007
Number of shared co-authors 8
Elai Davicioni
Veracyte Inc.
Career Start Year 2006
Number of shared co-authors 17
Tamara L Lotan
Johns Hopkins University School of Medicine
Career Start Year 2006
Number of shared co-authors 5
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 5
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 5
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 7
Adam Foye
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 2
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 3
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 6
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 8
Ilsa Coleman
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 4
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 3
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 5
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 1
Peter S Nelson
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 10
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 10
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 6
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 20
Gyorgy Petrovics
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
Career Start Year 1990
Number of shared co-authors 12
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 14

Collaborators

Hayley C Whitaker
University College London
Co-authored papers 15
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 14
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers 14
Charlie E Massie
University of Cambridge
Co-authored papers 13
Andy G Lynch
University of St Andrews
Co-authored papers 11
Hayley J Luxton
University College London
Co-authored papers 8
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 7
Nimish Shah
Cambridge University Hospitals NHS Foundation Trust
Co-authored papers 7
Vincent J Gnanapragasam
University of Cambridge
Co-authored papers 6
Alastair D Lamb
University of Oxford
Co-authored papers 6
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 5
Jeremy Clark
Norwich Medical School, University of East Anglia
Co-authored papers 5
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Co-authored papers 5
Helen J Ross
Mayo Clinic
Co-authored papers 5
Alan Thompson
The Royal Marsden NHS Foundation Trust
Co-authored papers 4
Adam Butler
Wellcome Sanger Institute
Co-authored papers 4
Naomi Livni
Royal Marsden NHS Foundation Trust
Co-authored papers 4
Mark J Dunning
The Medical School, The University of Sheffield
Co-authored papers 4
Jorge Zamora
Universidade de Santiago de Compostela
Co-authored papers 4
Peter Van Loo
The Francis Crick Institute
Co-authored papers 4
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 4
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 4
Nening Dennis
Institute of Cancer Research
Co-authored papers 4
Niedzica Camacho
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
David Jones
Wellcome Sanger Institute
Co-authored papers 4
Sandra Edwards
The Institute of Cancer Research
Co-authored papers 4
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 4
Ian G Mills
Queen's University Belfast
Co-authored papers 4
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 4
Barbara Kremeyer
University College London
Co-authored papers 4
Release 1.2